CG
AEGR

Cutler Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Cutler Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-33,800
Closed -$20K – 7954
2016
Q3 		$20K Buy
33,800
+32,700
+2,973% +$56.7K ﹤0.01% 3448
2016
Q2 		$8K Buy
1,100
+600
+120% +$1.37K ﹤0.01% 4511
2016
Q1 		$6K Sell
500
-2,300
-82% -$14.2K ﹤0.01% 4753
2015
Q4 		$59K Buy
+2,800
New +$33.7K ﹤0.01% 2297

Cutler Group's AEGR Position: Q4 2016 in Review

Cutler Group sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 4,641 shares — an estimated $13K sold.

Cutler Group first reported a position in AEGR in Q4 2015 and held it in 4 quarters. The position peaked at $15K in Q4 2015. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Cutler Group reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Cutler Group sold 4,641 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $13K.
  • Cutler Group first reported a position in Aegerion Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Cutler Group's Aegerion Pharmaceuticals position peaked at $15K in Q4 2015.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.